Galohgor Nutraceutical Supplementation Reduces Fasting Blood Glucose: A Pre-Post-Controlled Trial in Type 2 Diabetes Mellitus Patients

Authors

  • Katrin Roosita Department of Community Nutrition, Faculty of Human Ecology, IPB University, Bogor, 16680 Indonesia
  • Rimbawan Rimbawan Department of Community Nutrition, Faculty of Human Ecology, IPB University, Bogor, 16680 Indonesia
  • Ratih Putri Damayati Program Study of Clinical Nutrition, Politeknik Negeri Jember, Jember, 68175 Indonesia
  • Makiko Sekiyama National Institute for Environmental Studies, Ibaraki, 305-8506 Japan
  • Rosyanne Kushargina Nutrition Study Program, Faculty of Medicine and Health, Universitas Muhammadiyah Jakarta, Jakarta, 15419 Indonesia

DOI:

https://doi.org/10.65763/jfhb.2026.e269842

Keywords:

Type 2 diabetes mellitus, Galohgor, Indonesia, Nutraceuticals, Fasting blood glucose

Abstract

Galohgor nutraceutical (GN) is a polyherbal product from the Sundanese ethnic group in Indonesia. GN contains antioxidants and other bioactive compounds that have shown synergistic effects in controlling blood glucose in animal models and significantly decreasing oxidative stress in patients with Type 2 Diabetes Mellitus (T2DM). The aim of this study was to analyze the effect of GN on the fasting blood glucose (FBG) levels of T2DM subjects. A quasi-experimental pre-post-controlled trial design was conducted with 26 subjects divided into two groups: intervention and control. One subject from the control group and 6 from the GN group were excluded due to illness or voluntary withdrawal. The study was conducted in the Bogor District, West Java, over a 38-day intervention period. The formulation of the GN cookies and powdered drinks in the intervention group was similar to the control group, but supplemented with 2 g of GN powder daily, which was added in 24 g of cookies (containing 1 g of GN/serving size) and one pack of powdered drinks (containing 1 g of GN/serving size). The study received ethical approval (No.422/III/LPPM-PM.10.05/05/2016). Physical activity was measured using the International Physical Activity Questionnaire (IPAQ). Food intake data were obtained via a 24-h food record and recall combination at the beginning and during the intervention. The frequency of high glycemic index (GI) carbohydrate consumption was measured using a semi-quantitative food frequency questionnaire (SQ-FFQ). Differences in FBG between groups were tested using ANCOVA. At baseline, the FBG levels of the GN intervention and control groups were 267.5 mg/dL and 241.5 mg/dL, respectively. FBG significantly decreased in the GN intervention group compared to the control group (p<0.015). This study was limited by its quasi-experimental pre-post design and small sample size which may have introduced selection bias and limited generalizability. To elaborate on the potential effects and mechanisms of GN as an antidiabetic agent, further studies should be conducted with larger, randomized T2DM cohorts using standardized GN products.

References

Arif, S., Isdijoso, W., Fatah, A.R., & Tamyis, A.R. (2020). Strategic review of food security and nutrition in Indonesia: 2019–2020 update. The SMERU Research Institute.

Atkinson, F.S., Brand-Miller, J.C., Foster-Powell, K., Buyken, A.E., & Goletzke, J. (2021). International tables of glycemic index and glycemic load values 2021: A systematic review. The American Journal of Clinical Nutrition, 114(5), 1625–1632. https://doi.org/10.1093/ajcn/nqab233

Brand-Miller, J., Hayne, S., Petocz, P., & Colagiuri, S. (2003). Low–glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care, 26(8), 2261–2267. https://doi.org/10.2337/diacare.26.8.2261

Carvalho, K.M.M.B., Morais, T.C., de Melo, T.S., de Castro Brito, G.A., de Andrade, G.M., Rao, V.S., & Santos, F.A. (2010). The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice. Biological and Pharmaceutical Bulletin, 33(9), 1534–1539. https://doi.org/10.1248/bpb.33.1534

Caturano, A., D’Angelo, M., Mormone, A., Russo, V., Mollica, M.P., Salvatore, T., ... Sasso, F.C. (2023). Oxidative stress in type 2 diabetes: Impacts from pathogenesis to lifestyle modifications. Current Issues in Molecular Biology, 45(8), 6651–6666. https://doi.org/10.3390/cimb45080420

Damayati, E., Roosita, K., & Sulaeman, A. (2018). Effect of galohgor cookies and powder drinks on visceral adipose tissue and lipid profile in patients with type 2 diabetes mellitus. Jurnal Gizi dan Pangan, 13(3), 137–144. https://doi.org/10.25182/jgp.2018.13.3.137-144

Firdaus, F., Rimbawan, R., Marliyati, S.A., & Roosita, K. (2016). Role of nutraceutical Galohgor in maintenance of body weight and reducing blood glucose on diabetic rats induced by streptozotocin. Jurnal Aplikasi Teknologi Pangan, 5(3), 85–88. https://doi.org/10.17728/jatp.29

García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy, 4(2), 175–194. https://doi.org/10.1007/s13300-013-0034-y

Ghorbani, A. (2014). Clinical and experimental studies on polyherbal formulations for diabetes: Current status and future prospective. Journal of Integrative Medicine, 12(4), 336–345. https://doi.org/10.1016/S2095-4964(14)60031-5

Ghorbani, A., Rashidi, R., & Shafiee-Nick, R. (2019). Flavonoids for preserving pancreatic beta cell survival and function: A mechanistic review. Biomedicine & Pharmacotherapy, 111, 947–957. https://doi.org/10.1016/j.biopha.2018.12.127

Gómez‐Ambrosi, J., Silva, C., Galofré, J.C., Escalada, J., Santos, S., Gil, M.J., ... Frühbeck, G. (2011). Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI. Obesity, 19(7), 1439–1444. https://doi.org/10.1038/oby.2011.36

Hastuti, J. (2013). Anthropometry and body composition of Indonesian adults: An evaluation of body image, eating behaviours, and physical activity [Doctoral dissertation, Queensland University of Technology]. QUT ePrints. https://eprints.qut.edu.au/63737/

Indonesian Ministry of Health. (2018). Laporan nasional Riskesdas 2018 (Technical Report). National Institute of Health Research and Development. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514

Johnson, E.L., Feldman, H., Butts, A., Chamberlain, J., Collins, B., Doyle-Delgado, K., … Gabbay, R.A. (2021). Standards of medical care in diabetes—2021 abridged for primary care providers. Clinical Diabetes, 39(1), 14–43. https://doi.org/10.2337/cd21-as01

Kanaley, J.A., Colberg, S.R., Corcoran, M.H., Malin, S.K., Rodriguez, N.R., Crespo, C.J., ... Zierath, J.R. (2022). Exercise/physical activity in individuals with type 2 diabetes: A consensus statement from the American College of Sports Medicine. Medicine & Science in Sports & Exercise, 54(2), 353–368. https://doi.org/10.1249/MSS.0000000000002800

Mesquita, L. de A., Wayerbacher, L.F., Schwartsmann, G., & Gerchman, F. (2023). Obesity, diabetes, and cancer: Epidemiology, pathophysiology, and potential interventions. Archives of Endocrinology and Metabolism, 67(6), e000647. https://doi.org/10.20945/2359-3997000000647

Panche, A.N., Diwan, A.D., & Chandra, S.R. (2016). Flavonoids: An overview. Journal of Nutritional Science, 5, e47. https://doi.org/10.1017/jns.2016.41

Post, R.E., Mainous, A.G., King, D.E., & Simpson, K.N. (2012). Dietary fiber for the treatment of type 2 diabetes mellitus: A meta-analysis. The Journal of the American Board of Family Medicine, 25(1), 16–23. https://doi.org/10.3122/jabfm.2012.01.110148

Ramesh, V., Subbarayan, K., Viswanathan, S., & Subramanian, K. (2023). Role of nutraceuticals in the management of lifestyle diseases. In D. Shankaran & R.S.V. Raghavan (Eds.), Role of herbal medicines: Delivery systems and clinical applications (pp. 461–478). Springer Nature Singapore. https://doi.org/10.1007/978-981-99-7703-1_23

Rascón-Careaga, A., Corella-Madueño, M.A.G., Pérez-Martínez, C.J., García-Rojas, A.M., Souflé-Vásquez, S.Z., García-Moroyoqui, M.T., ... García-Alegría, A.M. (2021). Validation and estimation of uncertainty for a glucose determination method GOD-PAP using a multi-calibrator as reference. MAPAN - Journal of Metrology Society of India, 36(2), 269–278. https://doi.org/10.1007/s12647-021-00441-5

Riccardi, G., Rivellese, A.A., & Giacco, R. (2008). Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. The American Journal of Clinical Nutrition, 87(1), 269S–274S. https://doi.org/10.1093/ajcn/87.1.269S

Roosita, K., Ekawidyani, K.R., Kushargina, R., Fathimah, Rafi, M., & Saepuloh, U. (2024). Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects. Asia Pacific Journal of Clinical Nutrition, 33(4), 512–525. https://doi.org/10.6133/apjcn.202412_33(4).0006

Roosita, K., Ma’rifah, B., Nurdin, N.M., & Anwar, F. (2022). Effects of Galohgor nutraceutical lactation cookies on breast milk volume and lactose concentration. Korean Journal of Family Medicine, 43(1), 56–62. https://doi.org/10.4082/kjfm.20.0224

Roosita, K., Sa’diah, S., Wientarsih, I., & Rohadi, R. (2014). Optimasi proses ekstraksi nutrasetikal Galohgor. In Prosiding Simposium Penelitian Bahan Obat Alami (SPBOA) XVI dan Muktamar XII PERHIBPA 2014 (pp. 112–118). PERHIBPA.

Segatto, M., Rosso, P., Fioramonti, M., Fracassi, A., Marangoni, M., Taglietti, V., & Siteni, S. (2016). AMPK in the central nervous system: Physiological roles and pathological implications. Research and Reports in Biology, 7, 1–13. https://doi.org/10.2147/RRB.S90858

Setyaningsih, S., Roosita, K., & Damayanthi, E. (2017). Effect Galohgor’s product on antioxidant activity and decreased oxidative stress. Media Kesehatan Masyarakat Indonesia, 13(4), 310–316. https://doi.org/10.30597/mkmi.v13i4.1930

Tran, N., Pham, B., & Le, L. (2020). Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery. Biology, 9(9), 252. https://doi.org/10.3390/biology9090252

Utari, A., Maududi, M.S., Kusumawati, N.R.D., & Mexitalia, M. (2019). Effects of low glycemic index diet on insulin resistance among obese adolescent with non-alcoholic fatty liver disease: A randomized controlled trial. Medical Journal of Indonesia, 28(2), 123–128. https://doi.org/10.13181/mji.v28i2.2496

Wicaksono, M.A. (2010). Evaluation of liver and kidney function of female rats (Rattus norvegicus) Sprague-Dawley strain when given Galohgor herbal medicine [Undergraduate thesis, IPB University]. IPB Repository. https://repository.ipb.ac.id/handle/123456789/58811

World Health Organization. (2016). Global report on diabetes. https://iris.who.int/handle/10665/204871

Yadav, A., Kataria, M.A., Saini, V., & Yadav, A. (2013). Role of leptin and adiponectin in insulin resistance. Clinica Chimica Acta, 417, 80–84. https://doi.org/10.1016/j.cca.2012.12.007

Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., ... Kadowaki, T. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8(11), 1288–1295. https://doi.org/10.1038/nm788

Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., … Kadowaki, T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7(8), 941–946. https://doi.org/10.1038/90984

Yang, H., Lin, H., Liu, X., Liu, H., Chen, T., & Jin, Z. (2024). Association between dietary fiber intake and diabetic nephropathy among adult diabetes mellitus in the United States: A cross-sectional study. Heliyon, 10(9), e30036. https://doi.org/10.1016/j.heliyon.2024.e30036

Downloads

Published

2026-11-13

How to Cite

Roosita, K., Rimbawan, R., Damayati, R. P., Sekiyama, M., & Kushargina, R. (2026). Galohgor Nutraceutical Supplementation Reduces Fasting Blood Glucose: A Pre-Post-Controlled Trial in Type 2 Diabetes Mellitus Patients. Journal of Food Health and Bioenvironmental Science, 19(3), e269842. https://doi.org/10.65763/jfhb.2026.e269842

Similar Articles

You may also start an advanced similarity search for this article.